Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03956472
Other study ID # TAIA
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date June 17, 2017
Est. completion date July 31, 2019

Study information

Verified date August 2021
Source Institut de Formation et de Recherche en Médecine de Montagne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to support a hypothesis that osteopathic manual medicine (OMM) and / or a 10 cmH2O end-expiratory pressure (PEEP) could be used in the prevention of acute mountain sickness (AMS). During altitude exposure, an exaggerated hypoxemia and the increase of intracranial pressure are both known to be major physipathological ways of AMS development. The goal of the osteopathic protocol is to release tension on the circulatory structures directly related to cranial circulation and drainage. The main hypothesis is that it could lead to lower intracranial pressure and help reducing AMS signs. Furthermore the investigators would like to define a osteopathic score for individual AMS sensitivity, based on cranial bones mobility. Several studies have shown that using PEEP at altitude (or hypoxia) increases SpO2. As for osteopathy protocol, the investigators would like to apply this experimental condition during real altitude exposure in a randomized controlled protocol.


Recruitment information / eligibility

Status Terminated
Enrollment 50
Est. completion date July 31, 2019
Est. primary completion date October 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Healthy - Experienced alpinist - No previous acclimatization Exclusion Criteria: - Heart failure, respiratory failure, kidney failure - Pregnant woman

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Osteopathic protocol for improving drainage of LCS
Osteopathic intervention improving drainage of LCS and cerebral blood flow through opitmizing veinous circulation
Device:
PEEP 10cmH2O
Breathing through a 10 cmH2O expiratory resistance for 10 min every 2 hours during 10h at 3842m high
Other:
Fake Osteopathic protocol
Placebo intervention
PEEP-Sham
PEEP 0 cmH2O (hidden)

Locations

Country Name City State
France Ifremmont Chamonix

Sponsors (1)

Lead Sponsor Collaborator
Institut de Formation et de Recherche en Médecine de Montagne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Lake Louise Score from baseline to altitude continuous exposure. Signs of acute mountain sickness regarding its severity according the official Lake Louise Score. mesured and reported every hour during a 10 hours altitude exposure
Secondary Changes in numeric scale of well being from baseline to altitude continuous exposure. Quantification of general feeling on a scale from 0 (feeling as before ascent) to 10 (worst feeling) every hour during a 10 hours altitude exposure
See also
  Status Clinical Trial Phase
Completed NCT04111263 - Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude N/A
Completed NCT01842906 - Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID) N/A
Completed NCT01536288 - Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness Phase 2
Completed NCT00326703 - Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort N/A
Completed NCT06310642 - Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness Phase 4
Completed NCT03561675 - Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years Phase 4
Completed NCT00559832 - Prevention of Acute Mountain Sickness by Intermittent Hypoxia N/A
Completed NCT00603122 - Acclimatization Mechanisms During Ascent to 7500m N/A
Completed NCT01436383 - Oxidative Stress in Hypobaric Hypoxia N/A
Completed NCT00664001 - Anti-Oxidant Supplementation for the Prevention of Acute Mountain Sickness Phase 3
Completed NCT00627965 - Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness Phase 4
Not yet recruiting NCT06145113 - The Effect of Continuous Positive Pressure Ventilation on Symptoms of Acute Mountain Sickness N/A
Recruiting NCT05733338 - The Effects of Intermittent Hypoxia on Acute Hypoxic Injury N/A
Completed NCT01522326 - Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness N/A
Recruiting NCT06393998 - CO2 Supplement for Treatment of Acute Mountain Sickness N/A
Completed NCT03270787 - Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness Phase 1/Phase 2
Completed NCT02811016 - Inhaled Budesonide and Acute Mountain Sickness Phase 1
Recruiting NCT00886912 - Training in Hypoxia to Prevent Acute Mountain Sickness N/A
Recruiting NCT03621410 - T89 in Prevention and Treatment of Acute Mountain Sickness (AMS) During Rapid Ascent Phase 2
Active, not recruiting NCT01565603 - Sleep and Cerebral Responses to High Altitude N/A